Maximize Conference Impact Virtually – Engaging Your Advisors Creatively
July 10, 2025 |
Extend the impact of scientific conferences! Discover how to creatively empower your advisors to share patient cases and evidence, sparking rich discussions on clinical implications and research questions. Drive deeper engagement post-congress!
Transform your post-conference engagement and extend the life of valuable insights. Explore innovative ways to leverage virtual platforms for congress coverage and post-conference engagement initiatives. Empower your advisors to share patient cases, digest emerging evidence from sessions, and spark deep discussions on data significance, clinical implications, and unanswered research questions. Learn how to foster ownership and generate rich, ongoing dialogue long after the live event concludes.
- Congress Coverage and Post-Conference Engagement Initiatives
- Enable advisors to submit patient cases or evidence digests from live conferences.
- Facilitate thought-provoking discussions on data, clinical implications, and research questions.
- Empower advisors to moderate their own questions, fostering ownership and deeper engagement.
- Extend the impact of conference sessions through sustained virtual dialogue.
For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/
Learn more about Impetus Digital’s solutions: www.impetusdigital.com
Schedule a consultation: https://meetwithimpetus.com/
Stay connected:
- LinkedIn: https://linkedin.com/company/impetus-digital
- Twitter: https://twitter.com/impetus_digital
- Facebook: https://facebook.com/ImpetusDigital.fb
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
There’s No Going Back: How COVID-19 will Change Pharma Forever
Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches…
Powering Rapid Cognitive Analysis with AI
Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.
KOL Ambassador Program & Podcast Creation: A Customer Story
Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives…
Importance of Emotional Intelligence in Pharma and Medical Affairs
Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional…
Virtual product launch planning: the ultimate playbook
We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.
Artificial Intelligence for Identifying and Monitoring Cognitive Decline
Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.
Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic
While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear…
Navigating the Nuances of Europe’s MedTech Industry
Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and…
Pharma, Technology, and Healthcare in the New Normal
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with…
Traversing the Medtech Regulatory Landscape in the Interest of Patients
Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting…